Maxim Integrated Products has signed a ten year deal with a US university for medical wearable technology.
The $750,000 deal with the Querrey Simpson Institute for Bioelectronics (QSIB) at Northwestern University will help develop wireless, bio-integrated medical sensors. Northwestern spin out Sibel Systems has also received a $4.2m grant from the US Department fo Defense to roll out its Covid-19 wearable systems.
“Medical innovation doesn’t happen within a year or two,” said Prof John Rogers, executive director of QSIB and co-founder of Sibel. “Given this, we wanted to set a decade-long timeline focused on improving healthcare and patient outcomes with advanced, next-generation medical sensors.”
While the pledge is not tied to a specific project, the COVID-19 pandemic has jump-started the partnership says Rogers. His lab developed a clinical-grade medical device for detecting and monitoring COVID-19, which recently entered clinical trials.
“During this unprecedented health crisis, the work that we do in advanced and ubiquitous medical sensing has never been more important,” said Dr. Shuai “Steve” Xu, medical director of QSIB and lead architect of the partnership. “When we first learned about how Maxim Integrated was directing its resources to rapidly accelerate new integrated circuits to power next-generation sensors specifically for COVID-19, we knew we had to make this partnership happen.”
“When I first spoke to Professor Rogers and Dr. Xu to discuss this partnership, I was impressed to see how they are enabling their vision of remote patient monitoring,” said Shailendra Mahajan, managing director at Maxim Integrated and Maxim Ventures. “The lab has significant grants, strong healthcare ecosystem support and a capable team. This partnership will help Maxim Integrated’s business units look around the corner and help define compelling products. At Maxim Ventures, the corporate arm of Maxim Integrated, we enable innovation by investing in startups that continuously transform technology solutions in healthcare.”
The grant through the Medical Technology Enterprise Consortium will support the